The global prostate cancer therapeutics market accounted for US$ 11.4 Bn in 2018 and burgeoning over the forthcoming years. Some of the key factors propelling the market growth are various market players investing in the field of research for developing therapeutic products for treatment of tumors, growing incidences of glandular cancer, rising demand for non-invasive therapies and development of innovative technologies in screening & diagnostic tests. However, high cost of tissue biopsy ... Read more